DENNIS L. DeSILVEY, M.D.; ARTHUR J. MOSS, M.D.
▸Requests for reprints should be addressed to Arthur J. Moss, M.D.; Box 653, University of Rochester Medical Center, Rochester, NY 14642.
DeSILVEY D., MOSS A.; Primidone in the Treatment of the Long QT Syndrome: QT Shortening and Ventricular Arrhythmia Suppression. Ann Intern Med. 1980;93:53-54. doi: 10.7326/0003-4819-93-1-53
Download citation file:
Published: Ann Intern Med. 1980;93(1_Part_1):53-54.
We studied a family with the long QT syndrome. The initial case was in a patient who presented with seizures, ventricular fibrillation, and syncope. After a trial of conventional modalities of treatment including left stellate ganglionectomy, primidone (Mysoline) therapy was initiated. This drug has been successful in suppressing ventricular arrhythmias and shortening the QT interval over a 2-year follow-up period. Two additional family members with QT prolongation have been treated with primidone. During an 8-month follow-up, electrocardiographic and Holter recordings showed shortening of the QT interval.
to gain full access to the content and tools.
Learn more about subscription options.
Register Now for a free account.
Cardiology, Rhythm Disorders and Devices.
Results provided by:
Copyright © 2016 American College of Physicians. All Rights Reserved.
Print ISSN: 0003-4819 | Online ISSN: 1539-3704
Conditions of Use
This PDF is available to Subscribers Only